Friedreich's Ataxia Clinical Trials

34 clinical trials for Friedreich's Ataxia across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of SGT-212 Gene Therapy in Friedreich's Ataxia — RECRUITING · PHASE1
• Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA) — RECRUITING
• GABA and GSH in FRDA — RECRUITING
• Biomarkers in Friedreich's Ataxia — RECRUITING
• Electroencephalogram in Patients With Friedreich's Ataxia for the Study of the Structural and Functional Connectome. — RECRUITING · NA
• Long-Term Efficacy Study of Vatiquinone for the Treatment of Friedreich's Ataxia (FA) — NOT_YET_RECRUITING · PHASE3
• A Phase 3, 2-Part, Randomized, Double-Blind, Placebo-Controlled Study (Part 1) and Open-Label Extension (Part 2) to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Omaveloxolone (BIIB141) in Participants With Friedreich’s Ataxia Aged 2 to < 16 Years — TERMINATED · PHASE3
• Identification of mitochondrial biomarkers reflecting omaveloxolone treatment (in FA patients) — TERMINATED · PHASE4
• Cardiac Output and Fatigue in Friedreich's Ataxia — NOT_YET_RECRUITING · NA
• Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) — COMPLETED
• Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study — COMPLETED · PHASE3
• Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia — COMPLETED · PHASE3
• Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia — COMPLETED · PHASE3
• A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich's Ataxia (MOXIe) — OTHER · PHASE2
• Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia — COMPLETED · PHASE3
• Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients — COMPLETED · PHASE3
• A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia — COMPLETED · PHASE3
• Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND) — COMPLETED
• Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia — COMPLETED · PHASE1
• A First in Human Study of RT001 in Patients With Friedreich's Ataxia — COMPLETED · PHASE1
• Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia — COMPLETED · PHASE2
• (+) Epicatechin to Treat Friedreich's Ataxia — COMPLETED · PHASE2
• A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study) — COMPLETED · NA
• Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia — COMPLETED · PHASE2
• EPI-743 in Friedreich's Ataxia Point Mutations — COMPLETED · PHASE2
• A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients — COMPLETED · PHASE3
• An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia — OTHER · NA
• Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI) — COMPLETED · PHASE3
• Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept — COMPLETED · PHASE3
• Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia — TERMINATED · PHASE2
• A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia — COMPLETED · PHASE2
• Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia — COMPLETED · PHASE2
• A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia — COMPLETED · PHASE1
• Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia — COMPLETED · PHASE2

Refine this search